Literature DB >> 30171479

Recent Advances in Copper Intercalators as Anticancer Agents.

C Shobha Devi1, B Thulasiram2, Rajeshwar Rao Aerva3, Penumaka Nagababu4,5.   

Abstract

Copper is a part of various enzymes and helps them to function properly. It can be effectively used to produce promising anticancer drugs and presently, many studies are being pursued worldwide on the development of copper-based complexes as potential anticancer drugs. Herein, we briefly discuss the importance of reactive oxygen species in biological applications and copper(II) complexes as anticancer drugs. The anti-angiogenic properties of mono-nuclear copper(II) complexes have been demonstrated by in vivo chick embryo angiogenesis analysis. The plausible mechanism behind anticancer activity of these complexes is by the formation of excessive intracellular Reactive Oxygen Species (ROS). ROS is a composite term used for oxygen derivative non-radicals and free radicals of highly reactive components, that enhances the killing response of immune cells to microbial invasion. Previous reports have shown that ROS plays an important role as a messenger in cell cycling and normal cell signal transduction. Graphical Abstract The generation of singlet oxygen and healing the tumor cells with singlet oxygen in presence of UV-light.

Entities:  

Keywords:  Angiogenesis; Cancer; Copper; DNA; ROS

Mesh:

Substances:

Year:  2018        PMID: 30171479     DOI: 10.1007/s10895-018-2283-7

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  62 in total

Review 1.  Ruthenium(II) polypyridyl complexes and DNA--from structural probes to cellular imaging and therapeutics.

Authors:  Martin R Gill; Jim A Thomas
Journal:  Chem Soc Rev       Date:  2012-02-07       Impact factor: 54.564

2.  Steric and Electronic Effects, Enantiospecificity, and Reactive Orientation in DNA Binding/Cleaving by Substituted Derivatives of [SalenMn(III)](+).

Authors:  Dennis J. Gravert; John H. Griffin
Journal:  Inorg Chem       Date:  1996-08-14       Impact factor: 5.165

Review 3.  Advances in copper complexes as anticancer agents.

Authors:  Carlo Santini; Maura Pellei; Valentina Gandin; Marina Porchia; Francesco Tisato; Cristina Marzano
Journal:  Chem Rev       Date:  2013-10-08       Impact factor: 60.622

4.  Synthesis, characterization, thermal properties and antiproliferative potential of copper(II) 4'-phenyl-terpyridine compounds.

Authors:  Zhen Ma; Bian Zhang; M Fátima C Guedes da Silva; Joana Silva; Ana Soraia Mendo; Pedro Viana Baptista; Alexandra R Fernandes; Armando J L Pombeiro
Journal:  Dalton Trans       Date:  2016-03-28       Impact factor: 4.390

5.  Chemistry and biology of reactive oxygen species in signaling or stress responses.

Authors:  Bryan C Dickinson; Christopher J Chang
Journal:  Nat Chem Biol       Date:  2011-07-18       Impact factor: 15.040

Review 6.  Metals, toxicity and oxidative stress.

Authors:  M Valko; H Morris; M T D Cronin
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

Review 7.  Neurodegenerative diseases and oxidative stress.

Authors:  Kevin J Barnham; Colin L Masters; Ashley I Bush
Journal:  Nat Rev Drug Discov       Date:  2004-03       Impact factor: 84.694

Review 8.  Transition Metal Intercalators as Anticancer Agents-Recent Advances.

Authors:  Krishant M Deo; Benjamin J Pages; Dale L Ang; Christopher P Gordon; Janice R Aldrich-Wright
Journal:  Int J Mol Sci       Date:  2016-10-31       Impact factor: 5.923

9.  Heteroleptic Copper(I) Complexes of "Scorpionate" Bis-pyrazolyl Carboxylate Ligand with Auxiliary Phosphine as Potential Anticancer Agents: An Insight into Cytotoxic Mode.

Authors:  Rais Ahmad Khan; Mohammad Usman; Rajakumar Dhivya; Perumalsamy Balaji; Ali Alsalme; Hamad AlLohedan; Farukh Arjmand; Khalid AlFarhan; Mohammad Abdulkader Akbarsha; Fabio Marchetti; Claudio Pettinari; Sartaj Tabassum
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

10.  Insights into the mode of action of the anti-Candida activity of 1,10-phenanthroline and its metal chelates.

Authors:  M McCann; M Geraghty; M Devereux; D O'Shea; J Mason; L O'Sullivan
Journal:  Met Based Drugs       Date:  2000
View more
  8 in total

1.  Enhanced antitumor effect of L-buthionine sulfoximine or ionizing radiation by copper complexes with 2,2´-biquinoline and sulfonamides on A549 2D and 3D lung cancer cell models.

Authors:  J F Cadavid Vargas; C Villa Perez; D B Soria; A Guerci; A L Di Virgilio
Journal:  J Biol Inorg Chem       Date:  2022-03-05       Impact factor: 3.358

2.  Synthesis, Crystal Structure, and Computational Methods of Vanadium and Copper Compounds as Potential Drugs for Cancer Treatment.

Authors:  Nidia D Corona-Motolinia; Beatriz Martínez-Valencia; Lisset Noriega; Brenda L Sánchez-Gaytán; Miguel Ángel Méndez-Rojas; Francisco J Melendez; María Eugenia Castro; Enrique González-Vergara
Journal:  Molecules       Date:  2020-10-14       Impact factor: 4.411

Review 3.  Improvement in the Pharmacological Profile of Copper Biological Active Complexes by Their Incorporation into Organic or Inorganic Matrix.

Authors:  Mihaela Badea; Valentina Uivarosi; Rodica Olar
Journal:  Molecules       Date:  2020-12-10       Impact factor: 4.411

4.  A Novel Copper(II) Indenoisoquinoline Complex Inhibits Topoisomerase I, Induces G2 Phase Arrest, and Autophagy in Three Adenocarcinomas.

Authors:  Caroline Molinaro; Nathalie Wambang; Till Bousquet; Anne-Sophie Vercoutter-Edouart; Lydie Pélinski; Katia Cailliau; Alain Martoriati
Journal:  Front Oncol       Date:  2022-02-24       Impact factor: 6.244

5.  Synthesis, Structure, and Antiproliferative Action of 2-Pyridyl Urea-Based Cu(II) Complexes.

Authors:  Kirill K Geyl; Sergey V Baykov; Stanislav A Kalinin; Alexandr S Bunev; Marina A Troshina; Tatiana V Sharonova; Mikhail Yu Skripkin; Svetlana O Kasatkina; Sofia I Presnukhina; Anton A Shetnev; Mikhail Yu Krasavin; Vadim P Boyarskiy
Journal:  Biomedicines       Date:  2022-02-16

6.  Insights into Structure and Biological Activity of Copper(II) and Zinc(II) Complexes with Triazolopyrimidine Ligands.

Authors:  Aura Argăseală; Cătălin Maxim; Mihaela Badea; Larisa Ioniță; Mariana Carmen Chifiriuc; Arpad Mihai Rostas; Mihaela Bacalum; Mina Răileanu; Lavinia L Ruţă; Ileana C Farcaşanu; Emilia Elena Iorgulescu; Rodica Olar
Journal:  Molecules       Date:  2022-01-24       Impact factor: 4.411

Review 7.  Advances in thiosemicarbazone metal complexes as anti-lung cancer agents.

Authors:  Xian-Guang Bai; Yunyun Zheng; Jinxu Qi
Journal:  Front Pharmacol       Date:  2022-09-27       Impact factor: 5.988

8.  Induction of Redox-Mediated Cell Death in ER-Positive and ER-Negative Breast Cancer Cells by a Copper(II)-Phenolate Complex: An In Vitro and In Silico Study.

Authors:  Vaiyapuri Subbarayan Periasamy; Anvarbatcha Riyasdeen; Venugopal Rajendiran; Mallayan Palaniandavar; Hanumanthappa Krishnamurthy; Ali Abdullah Alshatwi; Mohammad Abdulkader Akbarsha
Journal:  Molecules       Date:  2020-10-01       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.